Antimicrobial Stewardship (IDSA Bundle)

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, Enjoy!

Issue link:

Contents of this Issue


Page 1 of 5

Key Points ÎÎOptimizing antimicrobial therapy minimizes antimicrobial resistance and adverse drug reactions. ÎÎIn one large cohort study of hospitalized patients, antimicrobials were the second most common cause of adverse events. ÎIn another study, antimicrobials were the class most frequently associated with Î prescribing errors. ÎÎMany antimicrobials have been associated with superinfection due to Clostridium difficile, causing morbidity ranging from diarrhea to life threatening colitis. ÎÎA properly framed discussion regarding implementation of a program must present usage and resistance data specific to the hospital, unit, and patient population in addition to the general issues of antimicrobial resistance. ÎÎThe main responsibility for an antimicrobial stewardship program rests on physicians and pharmacists. ÎÎAntimicrobial stewardship must operate 24/7 to be effective. ÎÎEducational activities are integral to successful antimicrobial stewardship – both its clinical and administrative aspects. >> A public-access web site is an excellent way to accomplish this. ÎÎActive auditing of prescribing practices is essential for determining the needs and targets of intervention. ÎÎIt is highly unlikely that any antimicrobial stewardship effort could be effective in the absence of information technology support. ÎÎAn adequate, institution-appropriate budget including personnel compensation is necessary for a successful program. ÎÎRecent payment rules from the Centers for Medicare and Medicaid Services specify that hospitals will no longer be reimbursed for certain nosocomial infections that are perceived to be avoidable. Other third-party payers are likely to follow suit. ÎÎRestriction of selected agents is often difficult to implement: >> entirely unavailable (formulary-based restriction) >> available for only certain indications (criteria-based restriction) >> available only after approval by some authority (preauthorization-based restriction)

Articles in this issue

Archives of this issue

view archives of IDSA GUIDELINES Bundle - Antimicrobial Stewardship (IDSA Bundle)